Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa
Journal of Global Oncology · 2018-12 · (4) · 1-9
DOI: 10.1200/jgo.17.00160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Oncology, 2018-12. Verfasst von Megan Johnson Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Megan Johnson Shen and Holly G. Prigerson, Weill Cornell Medical College; Judith S. Jacobson and Alfred I. Neugut, Columbia University, New York; Jam…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Themen: Palliativpflege
Abstract (Originalsprache)
Purpose
The understanding of patients with cancer of their condition and their wishes regarding care as they approach end of life (EoL) have been studied more in high-income countries than in low- and middle-income countries (LMICs). Patients and Methods Data were analyzed from a cohort study (N = 221) of patients with advanced cancer who were recruited from a palliative care center in Soweto, South Africa (LMIC), between May 2016 and June 2017. Patients were asked about their understanding of their illness, estimated life expectancy, EoL care communication, and EoL care preferences.
Results
Only 13 patients (5.9%) acknowledged that they were terminally ill; nine patients (4.1%) estimated accurately that they had months, not years, left to live. A total of 216 patients (97.7%) reported that they had not had an EoL care discussion with their physician, and 170 patients (76.9%) did not want to know their prognosis even if the doctor knew it. Most patients preferred comfort care (72.9%; n = 161) to life-extending care (14.0%; n = 31), and did not want to be kept alive using extreme measures (80.5%; n = 178) or have their doctors do everything possible to extend their lives (78.3%; n = 173). Finally, 127 patients (57.5%) preferred to die at home, and 51 (23.1%) preferred to die in the hospital. Most patients (81.0%; n = 179) had funeral plans.
Conclusion
South African patients demonstrated less awareness of the fact that they were terminally ill, were less likely to have discussed their prognosis with their doctor, and more strongly preferred comfort care to life-extending EoL care than US and other LMIC patients in prior research. These differences highlight the need for culturally appropriate, patient-centered EoL care for South African patients with advanced cancer as well as to determine individual preferences and needs in all EoL settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Megan Johnson Shen and Holly G. Prigerson, Weill Cornell Medical College; Judith S. Jacobson and Alfred I. Neugut, Columbia University, New York; Jamila Amanfu, Cornell University, Ithaca, NY; Mpho Ratshikana-Moloko, Ke…
Förderung
- NCI NIH HHS
Zitieren
APA
Shen, M. J., Prigerson, H. G., Ratshikana-Moloko, M., Mmoledi, K., Ruff, P., Jacobson, J. S., Neugut, A. I., Amanfu, J., Cubasch, H., Wong, M., Joffe, M., & Blanchard, C. (2018). Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. Journal of Global Oncology, 1-9. https://doi.org/10.1200/jgo.17.00160
Vancouver
Shen MJ, Prigerson HG, Ratshikana-Moloko M, Mmoledi K, Ruff P, Jacobson JS, et al. Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. Journal of Global Oncology. 2018:1-9. doi:10.1200/jgo.17.00160
BibTeX
@article{Shen2018,
author = {Shen, Megan Johnson and Prigerson, Holly G and Ratshikana-Moloko, Mpho and Mmoledi, Keletso and Ruff, Paul and Jacobson, Judith S and Neugut, Alfred I and Amanfu, Jamila and Cubasch, Herbert and Wong, Michelle and Joffe, Maureen and Blanchard, Charmaine},
title = {Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa},
journal = {Journal of Global Oncology},
year = {2018},
number = {4},
pages = {1--9},
doi = {10.1200/jgo.17.00160}
}
EUVIMED